Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Glyburide Patent Expiration

Glyburide was first introduced by Pfizer Inc in its drug Micronase on May 1, 1984. Other drugs containing Glyburide are Glynase, Diabeta, Glyburide (Micronized). 15 different companies have introduced drugs containing Glyburide.


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Glyburide Generic API Manufacturers

Several generic applications have been filed for Glyburide. The first generic version for Glyburide was by Teva Pharmaceuticals Usa Inc and was approved on Aug 29, 1995. And the latest generic version is by Orient Pharma Co Ltd and was approved on Feb 22, 2019.

Given below is the list of companies who have filed for Glyburide generic, along with the locations of their manufacturing plants worldwide.